
    
      Participants with MPS 7 who were UX003 treatment-na√Øve or previously enrolled and treated in
      a prior clinical study of UX003 (e.g. UX003-CL301 [NCT02230566], investigator sponsored
      trials, expanded access/compassionate use) can enroll into this treatment and extension study
      provided all eligibility criteria is met for a given participant.
    
  